ARCHIVES

Clinical Trials Approved By NCI CTEP Last Month

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

FDA’s Kweder cites Society of Professional Journalists’ Code of Ethics–incorrectly, SPJ says.

March 4, 2005

Phase II Elotuzumab Study Demonstrates 33 Months PFS

July 26, 2013

NCI, NSABP Launch Taxifin Trial For Prevention Of Breast Cancer

May 8, 1992

December Business & Regulatory Report included in this issue.

December 12, 2003

NCI Advisors Approve Three New Grant Programs; RFA, PA Available.

July 5, 2002

NCI advisors approve recompetition of $62 million phase II contracts program.

November 19, 2004